Wedge Capital Management L L P Ultragenyx Pharmaceutical Inc. Transaction History
Wedge Capital Management L L P
- $5.35 Billion
- Q2 2025
A detailed history of Wedge Capital Management L L P transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Wedge Capital Management L L P holds 35,805 shares of RARE stock, worth $1.48 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
35,805
Previous 35,695
0.31%
Holding current value
$1.48 Million
Previous $1.35 Million
3.56%
% of portfolio
0.02%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding RARE
# of Institutions
337Shares Held
89.8MCall Options Held
1.08MPut Options Held
1.04M-
Vanguard Group Inc Valley Forge, PA10MShares$414 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$232 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.16MShares$173 Million0.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.22MShares$133 Million0.01% of portfolio
-
State Street Corp Boston, MA2.62MShares$109 Million0.0% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.9B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...